Translational Epigenetics is a field of biotechnology that focuses on the study of epigenetic modifications, which are changes in gene expression that are not caused by changes in the underlying DNA sequence. It is a rapidly growing field, with research focusing on understanding how epigenetic modifications can be used to diagnose and treat diseases. This includes the development of drugs that target epigenetic modifications, as well as the use of epigenetic biomarkers to diagnose diseases.
Translational Epigenetics has the potential to revolutionize the way diseases are treated, as it can provide a more personalized approach to medicine. It also has the potential to improve the accuracy of diagnosis and reduce the cost of treatment.
Some companies in the Translational Epigenetics market include Epizyme, Inc., EpiTherapeutics, Inc., EpiVax, Inc., and EpiGeneSys, Inc. Show Less Read more
